cytarabine has been researched along with African Lymphoma in 231 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 69 (29.87) | 18.7374 |
| 1990's | 55 (23.81) | 18.2507 |
| 2000's | 56 (24.24) | 29.6817 |
| 2010's | 42 (18.18) | 24.3611 |
| 2020's | 9 (3.90) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, T; Borkar, S; Sahu, S; Sharma, MC | 1 |
| Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L | 1 |
| Abousaud, A; Orellana-Noia, V | 1 |
| Kobbe, R; Schmidtke, S; Schwärzler, P; Stang, A; Tolosa, E | 1 |
| Liu, L; Tan, L; Xie, Y; Yang, J | 1 |
| Allione, B; Calimeri, T; Cattaneo, C; Donadoni, G; Facchetti, F; Ferrari, D; Ferreri, AJM; Foppoli, M; Fumagalli, L; Lleshi, A; Pecciarini, L; Ponzoni, M; Re, A; Rigacci, L; Rossi, G; Sassone, M; Spina, M; Verga, L | 1 |
| Colton, BS; Glaspy, J; Hornstein, N; Larson, S; Timmerman, J | 1 |
| Hoover, A; Modi, A; Wiese, S; Zimmerman, JAO | 1 |
| Chauhan, P; Gupta, A; Mandelia, A; Nityanand, S; Rahman, K; Yadav, S | 1 |
| Chen, PY; Chuang, CC; Hsu, PW; Huang, YC; Jung, SM; Lin, TK; Tu, PH; Wei, KC; Yeh, TH | 1 |
| Ballester, C; Bargay, J; Bento, L; Cladera, A; Del Campo, R; Dominguez, J; García, L; García-Recio, M; Gines, J; Gutiérrez, A; Ruiz de Gracia, S; Sampol, A; Sartori, F | 1 |
| Baars, JW; Brouwer, R; Chamuleau, MED; de Jong, D; de Wreede, LC; Demandt, AMP; Doorduijn, JK; Hardi, L; Kersten, MJ; Kluin, PM; Nijland, M; Oosten, LEM; Siemes, C; Smeekes, OS; Stevens, WBC; Thielen, FW; Uyl-de Groot, CA; van Imhoff, GW; Veelken, H | 1 |
| Abou Mourad, Y; Barnett, MJ; Broady, R; Connors, JM; Forrest, DL; Gerrie, AS; Hogge, DE; Leitch, H; Nantel, SH; Narayanan, S; Nevill, TJ; Power, MM; Ramadan, K; Sanford, DS; Sehn, LH; Slack, GW; Song, KW; Sutherland, HJ; Toze, CL; Tucker, T; Zhu, KY | 1 |
| Geerlinks, A; Hitzler, J; Keis, J; Ngan, B; Shammas, A; Vali, R | 1 |
| Aladjidi, N; Auperin, A; Couec, ML; Gandemer, V; Haouy, S; Jourdain, A; Lambliotte, A; Landman-Parker, J; Leblanc, T; Michon, J; Minard-Colin, V; Patte, C; Plat, G; Rigaud, C | 1 |
| Brown, PN; D'Amore, F; Hagberg, H; Hagberg, O; Jerkeman, M; Pedersen, LM; Wästerlid, T | 1 |
| Choi, KH; Hyun, JY; Kim, JH; Kim, SJ; Kim, WS; Ko, YH; Lee, J; Lee, JY; Lim, SH | 1 |
| Dzietczenia, J; Fornagiel, S; Jurczak, W; Kumiega, B; Skotnicki, AB | 1 |
| Barr, PM; Caimi, PF; Carson, KR; Evens, AM; Gordon, LI; Gregory, SA; Helenowski, I; Islam, N; Jovanovic, B; Kolesar, J; Nabhan, C | 1 |
| Ajisawa, A; Hagiwara, S; Kitanaka, A; Kojima, Y; Nagai, H; Okada, S; Tanuma, J; Uehira, T | 1 |
| Chan, HN; Ha, CY; Lai, HK; Law, MF; Leung, C; Ng, C; Yeung, YM; Yip, SF | 1 |
| André, N; Ciccolini, J; Delarue, A; Fina, F; Lacarelle, B; Ouafik, L; Serdjebi, C; Verschuur, A | 1 |
| Anderson, JR; Barth, M; Cairo, MS; Frazer, JK; Galardy, P; Goldman, S; Gross, TG; Harrison, L; Perkins, SL; Sanger, W; Shiramizu, B; Smith, L; Weinstein, H | 1 |
| Jacobson, C; LaCasce, A | 1 |
| Maruyama, D | 2 |
| Beck, J; Burmeister, T; Dengler, J; Döhner, H; Domanska-Czyz, K; Dührsen, U; Fietkau, R; Gökbuget, N; Hertenstein, B; Hiddemann, W; Hoelzer, D; Horst, HA; Hüttmann, A; Kneba, M; Reichle, A; Rieder, H; Schaich, M; Schmidt-Wolf, IG; Schwartz, S; Serve, H; Spiekermann, K; Thiel, E; Viardot, A; Walewski, J | 1 |
| Ando, K; Kikuchi, T; Kikuti, YY; Kojima, M; Moriuchi, M; Murayama, H; Nakamura, N; Ogawa, Y; Tokunaka, M; Tsuboi, K; Yabe, M | 1 |
| Ambinder, R; Baiocchi, R; Cesarman, E; Kaplan, L; Lee, JY; Noy, A; Ratner, L; Reid, E; Wagner-Johnston, N | 1 |
| Boissel, N; Cluzeau, T; Dombret, H; Lengline, E; Raffoux, E; Segot, A; Thieblemont, C | 1 |
| Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD | 1 |
| Bendle, M; Boffito, M; Bower, M; Dalla Pria, A; Ramaswami, R | 1 |
| Gao, J; Guo, J; Guo, X; Jia, CS; Li, Q; Zhou, CY; Zhu, YP | 1 |
| Bosq, J; Cartron, G; Casasnovas, O; Chassagne-Clément, C; Coiffier, B; Cornillon, J; Dombret, H; Fornecker, LM; Ghesquieres, H; Girault, S; Koscielny, S; Lamy, T; Le Gouill, S; Leguay, T; Mariette, C; Morschhauser, F; Ojeda-Uribe, M; Recher, C; Ribrag, V; Salles, G; Tilly, H; Verge, V | 1 |
| Chang, SK; Choi, CH; Do, JH; Kim, HJ; Kim, JG; Kim, JW; Kim, MK; Lee, HW; Lee, SH; Mun, JS; Oh, HC | 1 |
| Browne, P; Giles, F; O'Rafferty, C; Swords, R | 1 |
| Barrans, SL; Clawson, SM; Jack, AS; Mead, GM; Qian, W; Radford, JA; Stenning, SP; Walewski, J; Wolf, M; Yule, CL | 1 |
| Griskevicius, L; Jurgutis, M; Kurtinaitis, J; Mickys, U; Pranys, D; Saulyte-Trakymiene, S; Stulpinas, R; Vengalyte, I | 1 |
| Choi, KA; Huh, W; Kim, DJ; Kim, K; Kim, WS; Kim, YG; Ko, YH; Lee, JE; Oh, HY | 1 |
| Boyd, K; Jenner, M; Kenny, J; Rhoades, E; Treleaven, J | 1 |
| Baleydier, F; Bertrand, Y; Kebaili, K; Mialou, V; Pages, MP; Pondarre, C; Pracros, JP | 1 |
| Aldoss, IT; Armitage, JO; Bierman, PJ; Bociek, RG; Chan, WC; Fu, K; Vose, JM; Weisenburger, DD | 1 |
| Choi, MK; Jun, HJ; Kim, K; Kim, KH; Kim, SJ; Kim, WS; Ko, YH; Lee, SY; Lim, DH | 1 |
| Jain, S; Kapoor, G; Naithani, R; Saha, R | 1 |
| Ayémou, R; Koffi, GK; Kouakou, B; Nanho, CD; Sanogo, I; Sawadogo, D; Siransi-Bogui, L; Tolo-Diebkilé, A | 1 |
| Baker, L; Cochrane, L; Delabie, J; Holte, H; Lauritzsen, GF; Mahendra, P; Roberts, C; Tauro, S | 1 |
| Hayashi, H; Kakimoto, T; Kurai, H; Mihara, A; Nakazato, T; Sanada, Y; Suzuki, K; Tachikawa, N; Yoshida, S; Yoshimura, Y | 1 |
| Alex, BK; Mattar, WE; Sherker, AH | 1 |
| Barboteau, MA; Brizard, F; Guilhot, F; Levillain, P; Loyer-Lecestre, MJ; Millot, F | 1 |
| Ayemou, R; Koffi, GK; Kouakou, B; Kouassi, MY; Kouehion, P; Meité, M; Meité, N; N'dathz, E; N'Diaye, FD; Nanho, DC; Sangaré, A; Sanogo, I; Sekongo, M; Tea, ND; Tolo, A | 1 |
| Bassan, R; Derigs, HG; Dombret, H; Gökbuget, N; Greil, R; Hartog, CM; Hernández-Rivas, JM; Hoelzer, D; Huguet, F; Intermesoli, T; Jourdan, E; Junghanss, C; Leimer, L; Moreno, MJ; Reichle, A; Ribera, J; Schmid, M; Serve, H; Stelljes, M; Stuhlmann, R | 1 |
| Azuma, T; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Nomoto, J; Taniguchi, H; Tobinai, K; Watanabe, T | 1 |
| Abramson, JS; Barnes, JA; Feng, Y; Hochberg, EP; Lacasce, AS; Michaelson, JS; Neuberg, D; Toomey, CE | 1 |
| Rodriguez, FR; Sudhakar, P; Trobe, JD | 1 |
| Chiba, S; Hasegawa, Y; Kondo, Y; Kurita, N; Nakamoto, R; Nakamura, N; Nishikii, H; Noguchi, M; Okoshi, Y; Suzukawa, K; Yokoyama, Y | 1 |
| Aparicio-Casans, T; González-García, I; López-Gómez, V; Moreno-Martínez, A | 1 |
| Arcamone, M; Becchimanzi, C; Capobianco, G; Corazzelli, G; De Chiara, A; De Filippi, R; Esposito, G; Frairia, C; Frigeri, F; Marcacci, G; Morelli, E; Pinto, A; Russo, F; Saggese, M; Vitolo, U; Volzone, F | 1 |
| Chiba, S; Enami, T; Hasegawa, Y; Kondo, Y; Nakamura, N; Nishikii, H; Noguchi, M; Okoshi, Y; Sakata-Yanagimoto, M; Suzukawa, K; Yokoyama, Y | 1 |
| Ambinder, RF; Bolaños-Meade, J; Borowitz, MJ; Brodsky, RA; Carraway, HE; Cho, SY; Crilley, PA; Gladstone, DE; Huff, CA; Jones, RJ; Kasamon, YL; Matsui, WH; Smith, BD; Swinnen, LJ; Tsai, HL | 1 |
| Adde, M; Adeodou, O; Aken'Ova, Y; Brown, BJ; Durosinmi, M; Githang'a, J; Hurwitz, N; Kaijage, J; Leoncini, L; Magrath, I; Naresh, K; Ngoma, T; Rajab, J; Raphael, M; Rohatiner, A; Scanlan, P; Venzon, D | 1 |
| Bruno Ventre, M; Caligaris-Cappio, F; Cattaneo, C; Di Nicola, M; Donadoni, G; Ferreri, AJ; Foppoli, M; Fumagalli, L; Govi, S; Mappa, S; Re, A; Rossi, G; Spina, M; Tirelli, U | 1 |
| Grigg, A; Guarnaccia, C; Hatton, CS; Lewis, MS; McKendrick, J; Mead, GM; Norbert, P; Pescosta, N; Stenning, SP; Sydes, MR; Walewski, J; Wright, D | 1 |
| Berkow, RL; Hilliard, LM; Watts, RG | 1 |
| Deschênes, G; Landman-Parker, J; Lucidarme, N; Nathanson, S | 1 |
| Falade, AG; Fasola, FA; Shokunbi, WA | 1 |
| Levine, AM | 1 |
| Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J | 1 |
| Corbacioglu, S; Eber, S; Gungor, T; Hummerjohann, J; Niggli, F | 1 |
| Centurioni, R; Corvatta, L; Leoni, F; Leoni, P; Malerba, L; Marconi, M; Masia, MC; Mele, A; Offidani, M; Scortechini, A | 1 |
| Anaclerico, B; Annino, L; Cimino, G; Cuneo, A; Di Raimondo, F; Elia, L; Fazi, P; Foa, R; Mancini, M; Mandelli, F; Mecucci, C; Pane, F; Recchia, A; Saglio, G; Specchia, G; Vitale, A | 1 |
| Adonis-Koffy, L; Boka, M; Koffi, G; Sangaré, A; Sawadogo, D; Timité-Konan, AM | 1 |
| Goy, A; Hedrick, E; Moskowitz, C; Noy, A; Portlock, C; Qin, J; Straus, DJ; Teruya-Feldstein, J; Wang, ES; Zelenetz, AD | 1 |
| Brunet, S; Esteve, J; Feliu, E; Fernández-Abellán, P; Ribera, JM; Sanz, MA; Xicoy, B | 1 |
| Ascani, S; Bonomini, S; Caramatti, C; Colla, S; Craviotto, L; Crugnola, M; De Celis, I; Giuliani, N; Hojden, M; Morandi, F; Rizzoli, V; Sabbatini, E; Sammarelli, G | 1 |
| Fortney, JE; Gibson, LF; Wang, L | 1 |
| Fisher, D; Howard, O; Lacasce, A; Lib, S; Neuberg, D; Shipp, M; Weng, A | 1 |
| Lau, JJ; Okada, CY; Trobe, JD | 1 |
| Cabras, A; Carlo-Stella, C; Devizzi, L; Di Nicola, M; Gandola, L; Gianni, AM; Guidetti, A; Magni, M; Mariotti, J; Massimino, M; Matteucci, P | 1 |
| Sun, XF; Wang, ZH; Wang, ZQ; Xia, Y; Zhang, CQ; Zhen, ZJ | 1 |
| Benchekroun, S; Benhmiddoune, L; Harif, M; Madani, A; Quessar, A; Zafad, S | 1 |
| Adediran, IA; Adeodu, OO; Akinola, NO; Kagu, BM; Kagu, MB; Salawu, L | 1 |
| Miyahara, S; Mizutani, M; Murabayashi, K; Ogawa, T; Yabana, T | 1 |
| Aygun, N; Sherman, PM | 1 |
| Bosq, J; Casassus, P; Diviné, M; Dupriez, B; Koscielny, S; Le Maignan, C; Pico, JL; Raphaël, M; Ribrag, V; Sebban, C; Stamattoulas, A | 1 |
| Magri, K; Maillet, R; Riethmuller, D | 1 |
| Bonutti, A; Cossaro, M; Di Loreto, C; Intini, S; Noce, L; Pecile, P; Saro, F; Terrosu, G | 1 |
| Amato, B; Billio, A; Coser, P; Morello, E; Svaldi, M | 1 |
| Lam, MS | 1 |
| Fätkenheuer, G; Goekbuget, N; Hentrich, M; Hoelzer, D; Hoffmann, C; Horst, HA; Jaeger, H; Noppeney, R; Plettenberg, A; Stellbrink, HJ; Stoehr, A; Van Lunzen, J; Wolf, E; Wyen, C | 1 |
| Ariola, C; De Gregoris, C; Foà, R; Guarini, A; Mandelli, F; Meloni, G; Mettivier, V; Pastorini, A; Perbellini, O; Pizzolo, G; Pizzuti, M; Vignetti, M; Vitale, A | 1 |
| Humphreys, P; Johnston, DL; Keene, DL; Pound, CM; Udjus, K | 1 |
| Barberi, W; Foa, R; Giona, F; Malandruccolo, L; Mandelli, F; Martino, P; Moleti, ML; Palumbo, G; Paoloni, F; Pescarmona, E; Testi, AM | 1 |
| Fujishima, M; Fujishima, N; Hirokawa, M; Inomata, M; Kameoka, Y; Saitoh, H; Saitoh, K; Sawada, K; Takahashi, N; Yamanaka, Y; Yoshioka, T | 1 |
| Borie, R; Daniel, MT; Fieschi, C; Galicier, L; Gérard, L; Meignin, V; Oksenhendler, E | 1 |
| Balta, Z; Büttner, R; Gütgemann, I; Lilienfeld-Toal, Mv; Rücker, Av; Schmidt-Wolf, IG; Schroers, E; Shimomura, A | 1 |
| Fujimoto, J; Kikuchi, A; Kumagai, M; Mori, T; Okimoto, Y; Sunami, S; Tsuchida, M | 1 |
| Chatzimichael, A; Kalmanti, M; Katzilakis, N; Mantadakis, E; Raissaki, M; Tzardi, M | 1 |
| Burchenal, JH; Dollinger, MR; Fox, JJ; Kreis, W | 1 |
| Clifford, P; Klein, G; Singh, S; Stjernswärd, J | 1 |
| David, R; Douay, L; Gorin, NC; Lecomte, D; Lopez, M; Najman, A; Oppenheimer, M; Parlier, Y; Salmon, C; Stachowiak, J | 1 |
| Klein, G; Moar, MH | 1 |
| Lamon, EW; Lidin, BI | 1 |
| Abe, I; Hori, K; Saito, S; Sato, H; Suzuki, M | 1 |
| Folami, AO; Seriki, O; Williams, CK | 1 |
| Edwards, B; Janus, C; Magrath, I; Sariban, E | 1 |
| Coccia, PF; Dehner, LP; Kersey, JH; Kim, TH; Krivit, W; Nesbit, ME; Ramsay, NK; Woods, WG | 1 |
| Greco, FA; Hande, KR; McDonough, DA; Stein, RS; Wolff, SN | 1 |
| Abe, I; Saito, S; Sato, H; Suzuki, M | 1 |
| Balow, JE; Cohen, LF; Magrath, IT; Poplack, DG; Ziegler, JL | 1 |
| Archimbaud, E; Charrin, C; Fiere, D; Magaud, JP; Thomas, X | 1 |
| Reiter, A | 1 |
| Frappaz, D; Leverger, G; Michon, J; Patte, C; Pico, JL; Rubie, H; Soussain, C | 1 |
| Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
| Büchner, T; Gale, RP; Hoelzer, D; Zittoun, R | 1 |
| Anderson, JR; Cecalupo, AJ; Finlay, JL; Hutchinson, RJ; Kadin, ME; Kjeldsberg, CR; Meadows, AT; Provisor, AJ; Woods, WG | 1 |
| Frierdich, S; Lee, Y; Moertel, CL; Morse, M; Nieder, M; Priest, JR; Toogood, I; Watterson, J | 1 |
| Droller, DG; Greenberg, AL | 1 |
| Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
| Klaus, G; Ludwig, R; Mehls, O; Pöschl, JM; Querfeld, U | 1 |
| al-Jarallah, MA; al-Jazzaf, H; Mechl, Z; Pandita, R; Patel, JG | 1 |
| Ben-Bassat, I; Mandel, M; Martinowitz, U; Neumann, Y; Ramot, B; Rechavi, G; Toren, A; Varon, D | 1 |
| Byrne, GE; Glaser, JS; Kay, MD; Liu, GT; Schatz, N | 1 |
| Bowman, PW; Civin, CI; Kastan, MB; Leventhal, BG; Phillips, PC; Resar, LM | 1 |
| Smith, PJ; Stevens, M; Tiedemann, K; Toogood, IR | 1 |
| Adair, S; Camitta, BM; Casper, JT; Civin, CI; Graham, M; Kiefer, G; Lauer, SJ; Leventhal, BG; Mahoney, DH; Shuster, JJ | 1 |
| Ballerini, E; Fossati-Bellani, F; Gasparini, M; Gianni, MC; Massimino, M; Pupa, S; Ravagnani, F; Rottoli, L | 1 |
| Andersen, JW; Hines, JD; Mann, R; Mazza, JJ; Neiman, RS; O'Connell, MJ; Oken, MM | 1 |
| Arnold, R; Aul, C; Büchner, T; Diedrich, H; Faak, T; Fabry, U; Fischer, K; Fonatsch, C; Freund, M; Fuhr, HG; Gassmann, W; Gökbuget, N; Gramatzki, M; Heil, G; Heinze, B; Heyll, A; Hiddemann, W; Hoelzer, D; Hossfeld, D; Ittel, TH; Koch, P; Kolbe, K; Kuse, R; Löffler, H; Ludwig, WD; Maschmeyer, G; Messerer, D; Metzner, B; Rieder, H; Schadeck-Gressel, C; Strohscheer, I; Thiel, E; Uberla, K; Völkers, B; Weiss, A | 1 |
| Behm, F; Berard, C; Bowman, WP; Carroll, A; Cook, B; Griffin, T; Head, D; Link, M; Murphy, S; Pullen, J; Shuster, JJ | 1 |
| Cremer, F; Döhner, H; Goldschmidt, H; Haas, R; Hunstein, W; Moos, M; Schmohl, D; Schulz, R; Sucker, C | 1 |
| Burke, M; Crawford, DH; Hunt, BJ; Thomas, JA; Walker, H; Yacoub, M | 1 |
| Ao, Z; Schlossman, SF; Seth, A; Zhang, C | 1 |
| Azar, N; Binet, JL; Boccaccio, C; Charlotte, F; Gabarre, J; Gentilini, M; Gonzalez, H; Jouan, M; Leblond, V; Sutton, L | 1 |
| Behm, FG; Camitta, BM; Downing, JR; Land, VJ; Link, MP; Pui, CH; Pullen, DJ; Rubnitz, JE; Shuster, JJ | 1 |
| Bergmann, L; Geissler, RG; Hacker, H; Hoelzer, D; Knupp, B; Walker, B | 1 |
| Balter, R; Degani, D; Franchini, M; Marradi, P; Meneghini, V; Perona, G; Ricetti, M; Tecchio, C; Todeschini, G; Zanotti, R | 1 |
| Cardenas-Cardos, R; Gómez-Martínez, R; Leal-Leal, C; Meza-Coria, C; Navarro-Alegría, I; Rivera-Luna, R; Vega-Vega, L | 1 |
| Okano, M | 1 |
| Bordigoni, P; Cahn, JY; Caillot, D; Cordonnier, JM; Deconinck, E; Esperou, H; Hervé, P; Jouet, JP; Leblond, V; Lioure, B; Milpied, N; Troussard, X; Vernant, JP | 1 |
| Hanazawa, T; Kimura, Y; Nagumo, M; Okano, T; Sakamaki, H; Yamaguchi, A | 1 |
| Ashley, S; Atra, A; Gerrard, M; Hobson, R; Imeson, JD; Pinkerton, CR | 1 |
| Behm, FG; Borowitz, MJ; Carroll, AJ; Harris, MB; Land, VJ; Pullen, DJ; Shuster, JJ | 1 |
| Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T | 1 |
| Kondo, E; Miura, A; Mizuno, H; Yamao, H; Yuge, M | 1 |
| Adamson, PC; Balis, FM; Gillespie, AJ; Moser, AM; Poplack, DG | 1 |
| Bigas, A; Chernukhin, IV; Delgado, MD; Klenova, EM; León, J | 1 |
| Alessandri, JL; Attali, T; Dubern, B; Montbrun, A; Pilorget, H; Samperiz, S | 1 |
| Koller-Lucae, SK; Schott, H; Schwendener, RA | 1 |
| Algara, P; Díaz, MA; Madero, L; Martínez, P; Tutor-Ureta, O | 1 |
| Bargetzi, M; Heitzmann, F; Obeid, L; Schär, B | 1 |
| Chott, A; Ebell, W; Graf, N; Henze, G; Klingebiel, T; Kremens, B; Ludwig, WD; Mann, G; Müller-Weihrich, S; Plüss, HJ; Reiter, A; Riehm, H; Schrappe, M; Tiemann, M; Yakisan, E; Zimmermann, M; Zintl, F | 1 |
| Cohen, IJ; Fischer, S; Goshen, Y; Mor, C; Stark, B; Stein, J; Yaniv, I; Zaizov, R | 1 |
| Hinson, RM; Lee, YJ; Sentürker, S; Shacter, E; Williams, JA | 1 |
| Behm, FG; Borowitz, MJ; Camitta, B; Carroll, AJ; Harris, MB; Land, VJ; Pullen, J; Shuster, JJ | 1 |
| Di Cataldo, A; Lo Nigro, L; Schiliro, G | 1 |
| Dastidar, P; Frey, H; Hietaharju, A; Honkaniemi, J; Kähärä, V; Kellokumpu-Lehtinen, P; Keskinen, L; Latvala, M; Ollikainen, J; Salonen, T; Vähämäki, L | 1 |
| Aranoff, GS; Feldstein, NA; Garvin, JH; Hays, AP; Levine, LS; Oberfield, SE; Silfen, ME; Starkman, HS; Wong, B | 1 |
| Atra, A; Gerrard, M; Hann, IM; Hobson, R; Imeson, JD; Pinkerton, CR | 1 |
| Bieszczad, CK; Cleaveland, ES; Craig, RW; Ma, Y; Mohandas, TK; Park, JP; Vrana, JA | 1 |
| Harris, E; Jackson, N; Jones, L; Mahendra, P; Paneesha, S | 1 |
| Casanova, M; Cefalo, GS; Collini, P; Ferrari, A; Fossati-Bellani, F; Gasparini, M; Luksch, R; Massimino, M; Polastri, D; Spreafico, F; Terenziani, M | 1 |
| Durodola, JI | 1 |
| Salem, PA | 1 |
| Igarashi, T; Kishimoto, T; Okada, M; Yamamura, Y | 1 |
| Magrath, IT; Olweny, CL; Ziegler, JL | 1 |
| Dölken, G; Klein, G | 1 |
| Giovanella, B; Klein, G; Mumford, D; Stehlin, JS; Westman, A | 1 |
| Hinuma, Y; Sairenji, T; Sekizawa, T; Yoshida, M | 1 |
| Hinuma, Y; Maeda, M; Sairenji, T | 1 |
| Applebaum, FR; Deisseroth, AB; Graw, RG; Ziegler, JL | 1 |
| Appelbaum, FR; Deisseroth, AB; Graw, RG; Herzig, GP; Levine, AS; Magrath, IT; Pizzo, PA; Poplack, DG; Ziegler, JL | 1 |
| Bluming, AZ; Magrath, IT; Ziegler, JL | 1 |
| Biggar, RJ; Nkrumah, FK; Perkins, IV | 1 |
| Herman, MM; Long, TF; Rubinstein, LJ; Wilbur, JR | 1 |
| Herman, MM; Long, TF; Rubinstein, JL; Wilbur, JR | 1 |
| Nkrumah, FK; Perkins, IV | 2 |
| Bailly, C; Cahn, JY; Carrie, C; Colombat, P; Dauriac, C; Deconnick, E; Demaille, MC; Meckenstock, R; Philip, T; Salles, B | 1 |
| Gadner, H; Harbott, J; Henze, G; Lampert, F; Ludwig, WD; Müller-Weihrich, S; Niemeyer, CM; Reiter, A; Ritter, J; Schrappe, M | 1 |
| Haake, R; Kersey, JH; Ramsay, NK; Uckun, FM; Weisdorf, D | 1 |
| Hoelzer, D | 1 |
| Behm, F; Borowitz, M; Bowman, P; Crist, W; Frankel, L; Krance, R; Look, T; Pullen, J; Shuster, J; Steuber, P | 1 |
| Blattner, SR; Lynch, E; Schwenn, MR; Weinstein, HJ | 1 |
| Foreman, NK; Mahmoud, H; Oakes, L; Tobias, JD | 1 |
| Aso, T; Ayabe, S; Hirota, Y; Ikematsu, W; Iwashita, A; Matsumoto, I; Matsuzaka, T; Okamura, H | 1 |
| Barnes, J; Eden, OB; Hann, IM; Pinkerton, CR | 1 |
| Chandanayingyong, D; Issaragrisil, S; Jirapinyo, P; Mahasandana, C; Suvatte, V; Tanphaichitr, VS | 1 |
| Durosinmi, MA; Lawal, OO; Ojo, OS | 1 |
| Bader-Meunier, B; Dommergues, JP; Garel, D; Venencie, PY | 1 |
| Anders, CU; Donhuijsen, K; Günzel, K; Höffken, K; Kath, R; Nowrousian, MR; Sack, H; Schmidt, CG | 1 |
| Armitage, JO; Bierman, PJ; Kessinger, A; Klassen, LW; Schouten, HC; Vaughan, WP; Weisenburger, D | 1 |
| Appelbaum, FR; Bigelow, CL; Buckner, CD; Clift, RA; Fefer, A; Petersen, FB; Sanders, JE; Storb, R; Sullivan, KM; Weiden, PL | 1 |
| Christian, ES; Diamond, BR; Saleh, MN | 1 |
| Ben-Sira, I; Cohen, S; Nissenkorn, I; Stark, B; Wysenbeek, YS; Zaizov, R | 1 |
| Abromowitch, M; Berard, CW; Bowman, WP; Fairclough, D; Mirro, J; Murphy, SB; Ochs, J; Pui, CH; Rivera, G | 1 |
| Pees, HW; Riehm, HJ; Schwamborn, J | 1 |
| Ettinger, LJ; Jones, GR | 1 |
| Dabich, L; Ensminger, WD; LoBuglio, AF; Wheeler, RH; Zuckerman, KS | 1 |
| Berard, CW; Bowman, WP; Hustu, HO; Murphy, SB | 1 |
| Clifford, P; Klein, E; Klein, G; Nadkarni, JJ; Nadkarni, JS; Wigzell, H | 1 |
| Zubrod, CG | 1 |
| Waldvogel, FA | 1 |
| Bluming, AZ; Fass, L; Iversen, OH; Morrow, RH; Ziegler, JL | 1 |
| Derge, JG; Hampar, B; Showalter, SD | 1 |
| Clifford, P; Demissie, A; Guerra, A; Gunvén, P; Henle, G; Henle, W; Hewetson, JF; Klein, G; Rocchi, G; Singh, S; Svedmyr, A | 1 |
| Ernberg, I; Klein, G; Kourilsky, FM; Silvestre, D | 1 |
| Chang, SY; Derge, JG; Hampar, B; Nonoyama, M; Showalter, SD; Tagamets, A | 1 |
| Glaser, R; Mele, J; Nonoyama, M; Rapp, F; Zimmerman, J | 1 |
| Gutjahr, P; Jung, H | 1 |
| Cappel, R; Thiry, L | 1 |
| Bailey, I; Kiryabwire, Y; Magrath, IT; Mugerwa, J; Olweny, C | 1 |
| Burchenal, JH; Cole, MT; Dowling, MD | 1 |
| Bodey, GP; Freireich, EJ; Rodriguez, V | 1 |
| Bluming, AZ; Carbone, PP; Magrath, IT; Ziegler, JL | 1 |
| Berchenal, J | 1 |
| Ziegler, JL | 1 |
| Frei, E | 1 |
| Alexander, LL; Atkins, NM | 1 |
| Cunningham, JJ; Dunnick, NR | 1 |
| Ravina, A | 1 |
| Gergely, L; Hewetson, J; Klein, G; Yata, J | 1 |
| Taylor, WJ | 1 |
| Ernberg, I; Gergely, L; Klein, G | 1 |
| Bluming, AZ; Ziegler, JL | 1 |
| Holland, JF | 1 |
| Henderson, ES | 1 |
| White, LP | 1 |
| Carbone, PP; Fass, L; Kyalwazi, SK; Morrow, RH; Ziegler, JL | 2 |
| Bluming, AZ; Carbone, PP; Fass, L; Morrow, RH; Ziegler, JL | 1 |
| Falco, EA; Fox, JJ | 1 |
19 review(s) available for cytarabine and African Lymphoma
| Article | Year |
|---|---|
Secondary Central Nervous System Lymphoma: Updates in Treatment and Prophylaxis Strategies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System; Central Nervous System Neoplasms; Cytarabine; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasms, Second Primary; Rituximab | 2022 |
Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Methotrexate; Postpartum Period; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Rituximab; Vincristine | 2020 |
Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Ifosfamide; Male; Methotrexate; Prednisone; Remission Induction; Sarcoma, Ewing; Young Adult | 2013 |
Burkitt-like post-transplant lymphoproliferative disorder (PTLD) presenting with breast mass in a renal transplant recipient: a report of a rare case.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Immunophenotyping; Kidney Transplantation; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Postoperative Complications; Remission Induction; Vincristine | 2014 |
[Treatment strategy of gray zone lymphomas].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Rituximab; Vincristine | 2014 |
Adult Burkitt lymphoma: advances in diagnosis and treatment.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Clinical Trials, Phase II as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Genes, myc; Humans; Ifosfamide; Leucovorin; Methotrexate; Practice Guidelines as Topic; Prednisone; Prognosis; Rituximab; Stem Cell Transplantation; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 2008 |
[Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Rituximab; Vincristine | 2011 |
Challenges in the management of Burkitt's lymphoma.
Topics: Adult; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Burkitt Lymphoma; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Enzyme Inhibitors; Etoposide; HIV Infections; Humans; Ifosfamide; Leucovorin; Methotrexate; Time Factors; Treatment Outcome; Urate Oxidase; Vincristine | 2002 |
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Heart Transplantation; Humans; Ifosfamide; Immunosuppression Therapy; Kidney Transplantation; Leucovorin; Liver Transplantation; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Remission Induction; Retrospective Studies; Transplantation; Treatment Outcome; Vincristine | 2003 |
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction | 2004 |
Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Germany, West; Humans; Infant; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Meninges; Methotrexate; Multicenter Studies as Topic; Prednisolone; Prognosis; Remission Induction; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 1994 |
Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, B-Cell; Male; Methotrexate; Multicenter Studies as Topic; Nasopharyngeal Neoplasms; Neoplasm Staging; Prednisone; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1994 |
Adult acute leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Humans; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Survival Rate; Treatment Outcome | 1994 |
Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Female; Humans; Male; Methotrexate; Radiotherapy; Spinal Cord; Spinal Cord Neoplasms; Spinal Diseases; Thiotepa | 1994 |
Burkitt's lymphoma involving the mandible: report of a case and review of Japanese cases.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Humans; Hydrocortisone; Japan; Male; Mandibular Neoplasms; Methotrexate; Prednisone; Soft Tissue Neoplasms | 1998 |
Advances in cancer chemotherapy.
Topics: Bleomycin; Burkitt Lymphoma; Carcinoma, Basal Cell; Choriocarcinoma; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitosis; Neoplasms; Pregnancy; Skin Neoplasms; Vincristine | 1975 |
Combination chemotherapy for lymphomas and leukemias.
Topics: Adult; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Hodgkin Disease; Humans; Immunotherapy; Infections; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Mercaptopurine; Methotrexate; Middle Aged; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Vincristine | 1973 |
[Achievements in the treatment of leukemia and lymphoma].
Topics: Acute Disease; Animals; Antineoplastic Agents; Burkitt Lymphoma; Chemical Phenomena; Chemistry; Cytarabine; Drug Therapy, Combination; Humans; Immunotherapy; Leukemia; Lymphoma; Methods; Remission, Spontaneous; Time Factors | 1973 |
[Burkitt's lymphoma and acute leukemias].
Topics: Acute Disease; Animals; Asparaginase; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Fluorouracil; Humans; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mice; Oncogenic Viruses; Prednisolone; Prednisone; Vincristine | 1969 |
44 trial(s) available for cytarabine and African Lymphoma
| Article | Year |
|---|---|
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Transplantation, Autologous | 2021 |
Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; France; Humans; Ifosfamide; Infant; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Prospective Studies; Recurrence; Rituximab; Survival Rate | 2019 |
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2013 |
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Humans; Immunotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Lymphoma, B-Cell; Maintenance Chemotherapy; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Typhlitis; Vincristine | 2014 |
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Injections, Spinal; Leukemia; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Rituximab; Young Adult | 2014 |
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; HIV Infections; HIV-1; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2015 |
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; France; Humans; Hydrocortisone; Injections, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Staging; Odds Ratio; Patient Selection; Prednisone; Proportional Hazards Models; Rituximab; Treatment Outcome; Vincristine | 2016 |
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Cytogenetic Analysis; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunophenotyping; Methotrexate; Middle Aged; Treatment Outcome; Vincristine | 2008 |
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Survival Analysis; Vincristine; Vindesine; Young Adult | 2010 |
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Central Nervous System Neoplasms; Cytarabine; Female; Humans; International Agencies; Liposomes; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Young Adult | 2011 |
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cytarabine; Disease-Free Survival; Female; Humans; Injections, Spinal; Liposomes; Lymphoma, B-Cell; Male; Middle Aged; Rituximab | 2012 |
Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; Leukemia; Male; Methotrexate; Middle Aged; Mucositis; Neutropenia; Prednisone; Remission Induction; Rituximab; Time Factors; Treatment Outcome; Vincristine | 2013 |
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
Topics: Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Methotrexate; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2012 |
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United Kingdom; Vincristine | 2002 |
High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bone Marrow Diseases; Burkitt Lymphoma; Comorbidity; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Carriers; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Infections; Leukemia, T-Cell; Life Tables; Liposomes; Male; Methotrexate; Middle Aged; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Safety; Survival Analysis; Topotecan; Treatment Outcome | 2003 |
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Fusion Proteins, bcr-abl; Genotype; Humans; Male; Middle Aged; Oncogene Proteins, Fusion; Prednisone; Treatment Outcome; Vincristine | 2003 |
Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leucovorin; Mesna; Methotrexate; Middle Aged; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine | 2005 |
Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; CD4 Lymphocyte Count; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Treatment Outcome; Vincristine | 2007 |
Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Lymphoma, B-Cell; Methotrexate; Neoplasms, Second Primary; Recurrence; Survival Analysis; Treatment Outcome | 2008 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 1994 |
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisolone; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1993 |
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Remission Induction; Survival Rate; Vincristine | 1995 |
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Blotting, Southern; Burkitt Lymphoma; Case-Control Studies; Child; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 21; Core Binding Factor Alpha 2 Subunit; Cytarabine; DNA, Neoplasm; Female; Humans; Hydrocortisone; Male; Mercaptopurine; Methotrexate; Neoplasm Proteins; Oncogene Proteins, Fusion; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Single-Blind Method; Translocation, Genetic; Treatment Outcome; Vincristine | 1997 |
Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Treatment Outcome; Vincristine | 1997 |
B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Humans; Immunophenotyping; Infant; Life Tables; Male; Mercaptopurine; Methotrexate; Neprilysin; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Risk Factors; Survival Analysis; Teniposide; Treatment Outcome; Vincristine | 1997 |
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Melphalan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Whole-Body Irradiation | 1997 |
Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydrocortisone; Infant; Lymphoma, B-Cell; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prednisone; Treatment Outcome; Vincristine | 1998 |
Consolidation therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: a Pediatric Oncology Group Study.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child, Preschool; Cytarabine; Female; Humans; Leucovorin; Male; Methotrexate; Recurrence; Remission Induction | 1998 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 1998 |
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Treatment Outcome; Vincristine | 1999 |
Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group Study.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Double-Blind Method; Female; Humans; Infant; Male; Methotrexate; Treatment Outcome | 2000 |
Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Spinal; Male; Methotrexate; Palliative Care; Prognosis; Risk Factors; Treatment Outcome; Vincristine | 2002 |
Cure of Burkitt's lymphoma. Ten-year follow-up of 157 Ugandan patients.
Topics: BCG Vaccine; Burkitt Lymphoma; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Follow-Up Studies; Humans; Meningeal Neoplasms; Methotrexate; Random Allocation; Remission, Spontaneous; Time Factors; Vincristine | 1979 |
Burkitt's lymphoma--a model for intensive chemotherapy.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Male; Nitrosourea Compounds; Remission, Spontaneous; Thioguanine; Transplantation, Autologous | 1977 |
Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Flow Cytometry; Humans; Hydrocortisone; Immunophenotyping; Infant; Infant, Newborn; Leukemia-Lymphoma, Adult T-Cell; Mercaptopurine; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Vincristine | 1992 |
HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Feasibility Studies; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Staging; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Vincristine | 1991 |
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Clinical Trials as Topic; Combined Modality Therapy; Cytarabine; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Whole-Body Irradiation | 1989 |
Advanced stage (III-IV) Burkitt's lymphoma and B-cell acute lymphoblastic leukaemia in children: kinetic and pharmacologic rationale for treatment and recent results (1979-1983).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Burkitt Lymphoma; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Humans; Leukemia, Lymphoid; Male; Neoplasm Staging; Vincristine | 1985 |
Intensive chemotherapy in patients with generalized Burkitt's lymphoma.
Topics: Abdominal Neoplasms; Adolescent; Adult; Bone Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Facial Neoplasms; Female; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplastic Cells, Circulating; Remission, Spontaneous; Thoracic Neoplasms; Vincristine | 1972 |
Current trends in clinical pharmacology in the USA.
Topics: Animals; Asparaginase; Burkitt Lymphoma; Cannabis; Carcinogens; Clinical Trials as Topic; Contraceptives, Oral; Cyclamates; Cyclophosphamide; Cytarabine; Female; Humans; Legislation, Drug; Leukemia; Pharmacology; Psychology, Adolescent; Substance-Related Disorders; Thromboembolism; United States; United States Food and Drug Administration; Uterine Cervical Neoplasms | 1970 |
Intrathecal chemotherapy in Burkitt's lymphoma.
Topics: Adolescent; Burkitt Lymphoma; Cerebrospinal Fluid; Child; Child, Preschool; Cytarabine; Humans; Injections, Spinal; Methotrexate | 1971 |
168 other study(ies) available for cytarabine and African Lymphoma
| Article | Year |
|---|---|
Primary intradural extramedullary spinal Burkitt's lymphoma mimicking a nerve sheath tumor: a case report.
Topics: Burkitt Lymphoma; Cytarabine; Humans; Ifosfamide; Male; Middle Aged; Nerve Sheath Neoplasms; Treatment Outcome | 2022 |
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine | 2022 |
[Effect of Modified LMB 89± Rituximab Regimen on Long-Term Benefits for Patients's with Burkitt Lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Treatment Outcome | 2020 |
Nivolumab Treatment of Burkitt Lymphoma: A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nivolumab; Vincristine | 2021 |
Evaluation of Empiric Vancomycin for Fevers During High-dose Cytarabine Administration.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bacteremia; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Female; Fever; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Prognosis; Retrospective Studies; Vancomycin; Young Adult | 2021 |
Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease Management; Doxorubicin; Female; Humans; Male; Methotrexate; Prednisone; Treatment Outcome; Vincristine | 2021 |
Primary Central Nervous System Lymphomas of the Brain: A Retrospective Analysis in a Single Institution.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Burkitt Lymphoma; Cranial Irradiation; Craniotomy; Cytarabine; Cytoreduction Surgical Procedures; Female; Humans; Injections, Spinal; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neurosurgical Procedures; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2017 |
Analysis of the role of intratecal liposomal cytarabine in the prophylaxis and treatment of central nervous system lymphomatosis: The Balearic Lymphoma Group experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Cytarabine; Female; Humans; Injections, Spinal; Liposomes; Male; Middle Aged; Survival Analysis; Young Adult | 2017 |
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustine; Cost-Benefit Analysis; Cyclophosphamide; Cytarabine; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Survival Analysis | 2018 |
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Survival Rate; Time Factors; Vincristine | 2018 |
Unusual lymphoid malignancy and treatment response in two children with Down syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Down Syndrome; Herpesvirus 4, Human; Humans; Male; Methotrexate; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; T-Lymphocytes | 2019 |
Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Denmark; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Multivariate Analysis; Retrospective Studies; Rituximab; Sweden; Treatment Outcome; Vincristine; Young Adult | 2013 |
[Liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas].
Topics: Adult; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Central Nervous System Neoplasms; Cytarabine; Drug Carriers; Female; Follow-Up Studies; Humans; Liposomes; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Young Adult | 2013 |
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Japan; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2014 |
Recipient/donor contradictory genotypes with impact on drug pharmacogenetics after liver transplant: a deadly gift?
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Child, Preschool; Cytarabine; Cytidine Deaminase; Dose-Response Relationship, Drug; Female; Germ-Line Mutation; Humans; Liver Transplantation; Polymorphism, Genetic | 2014 |
How I treat Burkitt lymphoma in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nasopharyngeal Neoplasms; Prednisone; Prognosis; Translocation, Genetic; Vincristine | 2014 |
A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Male; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Remission Induction; V(D)J Recombination; Vincristine | 2015 |
Liposomal cytarabine in prophylaxis or curative treatment of central nervous system involvement in Burkitt leukemia/lymphoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Central Nervous System Neoplasms; Chemoprevention; Cranial Irradiation; Cytarabine; Female; Humans; Liposomes; Male; Middle Aged; Retrospective Studies; Young Adult | 2015 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine | 2016 |
The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Female; Half-Life; HIV Infections; Humans; Ifosfamide; Kidney Function Tests; Male; Methotrexate; Middle Aged; Retrospective Studies; Tenofovir; Vincristine; Young Adult | 2016 |
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Logistic Models; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Multivariate Analysis; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 2016 |
A case of primary hepatic Burkitt's lymphoma.
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Combined Modality Therapy; Cytarabine; Diagnosis, Differential; Humans; Liver Neoplasms; Male; Methotrexate; Tomography, X-Ray Computed; Young Adult | 2008 |
Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.
Topics: Adult; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Cerebrospinal Fluid; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Liposomes; Male; Middle Aged; Remission Induction; Reproducibility of Results | 2008 |
Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Dexamethasone; Female; Humans; Immunotherapy; Male; Methotrexate; Middle Aged; Neoplasm Staging; Rituximab; Treatment Outcome | 2009 |
Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hemofiltration; Humans; Hydrocortisone; Hyperuricemia; Kidney Function Tests; Leucovorin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk; Survival Analysis; Tumor Lysis Syndrome; Vincristine | 2009 |
Liposomal cytarabine in cerebrospinal fluid.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Injections, Spinal; Liposomes; Male; Methotrexate; Middle Aged; Vincristine | 2009 |
Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome | 2008 |
Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Korea; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sepsis; Treatment Outcome; Vincristine; Young Adult | 2009 |
Chemotherapy-induced palmoplantar erythrodysesthesia in a child with Burkitt lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Child, Preschool; Cytarabine; Etoposide; Foot Dermatoses; Hand Dermatoses; Humans; Male; Paresthesia | 2009 |
[Evaluation of the protocol CMA reinforced in the treatment of endemic Burkitt lymphoma at CHU of Yopougon in Abidjan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cote d'Ivoire; Cyclophosphamide; Cytarabine; Facial Neoplasms; Female; Humans; Infant; Infant, Newborn; Male; Maxillary Neoplasms; Methotrexate; Remission Induction | 2010 |
[Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Colonic Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Prednisone; Treatment Outcome; Vincristine | 2010 |
Primary hepatic burkitt lymphoma presenting with acute liver failure.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cytarabine; Dexamethasone; Female; HIV Infections; Humans; Liver Failure, Acute; Liver Neoplasms; Middle Aged; Rituximab | 2010 |
Endoscopic diagnosis of childhood Burkitt's lymphoma of the colon.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Colonic Neoplasms; Colonoscopy; Cyclophosphamide; Cytarabine; Female; Humans; Methotrexate | 2010 |
Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharian Africa: experience of Côte d'Ivoire.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cote d'Ivoire; Cyclophosphamide; Cytarabine; Female; Humans; Male; Methotrexate; Treatment Outcome | 2010 |
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2010 |
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Secondary Prevention; Vincristine | 2011 |
MRI restricted diffusion in lymphomatous optic neuropathy.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cytarabine; Humans; Injections, Spinal; Magnetic Resonance Imaging; Male; Methotrexate; Optic Nerve Neoplasms; Rituximab | 2011 |
A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Fatal Outcome; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Proto-Oncogene Proteins c-bcl-2 | 2011 |
What is your guess? Which count is correct?
Topics: Aged; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Cytarabine; False Positive Reactions; Female; Humans; Leukocyte Count; Liposomes; Meningeal Neoplasms | 2011 |
Treatment outcome of adult Burkitt Lymphoma in Japanese patients with modified LMB protocol : a single center retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Japan; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult | 2011 |
Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustine; Cytarabine; Female; HIV Seropositivity; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Stem Cell Transplantation; Transplantation, Autologous | 2012 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Long-term survival of renal graft complicated with Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Creatinine; Cyclosporine; Cytarabine; Graft Survival; Humans; Immunosuppressive Agents; Infant; Kidney Neoplasms; Kidney Transplantation; Liver Neoplasms; Male; Nephrotic Syndrome; Splenic Neoplasms | 2002 |
Factors determining the outcome of management of patients with Burkitt's lymphoma at the University College Hospital Ibadan, Nigeria--an eleven year review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Drug and Narcotic Control; Female; Humans; Male; Neoplasm Staging; Nigeria; Retrospective Studies; Treatment Outcome | 2002 |
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine | 2003 |
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Burkitt Lymphoma; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Humans; Immunotherapy; Leukemic Infiltration; Male; Meninges; Methotrexate; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Testis; Topotecan; Transplantation, Autologous; Vindesine | 2003 |
[Sub-cutaneous location of Burkitt's lymphoma. Apropos of 1 case at Yopougon Central University Hospital, Abidjan (Côte d'Ivoire)].
Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cote d'Ivoire; Cyclophosphamide; Cytarabine; Humans; Male; Methotrexate | 2003 |
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Retrospective Studies | 2003 |
Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt.
Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Cell Survival; Coculture Techniques; Cytarabine; Etoposide; Humans; Mice; Phosphoprotein Phosphatases; Phosphorylation; Poly(ADP-ribose) Polymerases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Stromal Cells | 2004 |
Galloping ophthalmoplegia and numb chin in Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chin; Cytarabine; Humans; Hydrocortisone; Hypesthesia; Male; Methotrexate; Middle Aged; Ophthalmoplegia; Remission Induction; Tomography, X-Ray Computed | 2004 |
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2004 |
[Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vascular Endothelial Growth Factor A; Vincristine | 2004 |
[Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Male; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Analysis; Vincristine | 2005 |
Determinants of survival in Nigerians with Burkitt's lymphoma.
Topics: Adolescent; Adult; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Male; Methotrexate; Middle Aged; Nigeria; Prognosis; Retrospective Studies; Sex Distribution; Survival Analysis; Vincristine | 2004 |
A Case of Burkitt's Lymphoma Involving Both Breasts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine | 2005 |
Development of a cavum septi pellucidi after Ommaya reservoir placement: report of an unusual complication.
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Burkitt Lymphoma; Catheters, Indwelling; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Epilepsy, Tonic-Clonic; Humans; Infusion Pumps, Implantable; Injections, Intraventricular; Lateral Ventricles; Magnetic Resonance Imaging; Male; Postoperative Complications; Reoperation; Septum Pellucidum; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
[Pelvic Burkitt lymphoma mimicking an ovarian tumor].
Topics: Adult; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Cytarabine; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Ovarian Neoplasms; Pelvic Pain; Treatment Outcome | 2006 |
[An abdominal Burkitt's lymphoma in acute phase. Case report].
Topics: Acute Disease; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Appendicitis; Burkitt Lymphoma; Cytarabine; Diagnosis, Differential; Humans; Ileal Neoplasms; Immunohistochemistry; Liver Neoplasms; Male; Methotrexate; Radiography, Abdominal; Remission Induction; Tomography, X-Ray Computed; Ultrasonography | 2006 |
A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high-dose cytarabine.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cytarabine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Injections, Intraventricular; Male; Recurrence; Remission Induction; Rituximab; Treatment Outcome | 2006 |
Treatment of Burkitt's lymphoma during pregnancy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant, Newborn; Male; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Registries; Vincristine | 2006 |
AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Lymphoma, AIDS-Related; Male; Mercaptopurine; Prednisolone; Prednisone; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2006 |
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Burkitt Lymphoma; CD13 Antigens; Cell Lineage; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Multicenter Studies as Topic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Remission Induction; Sialic Acid Binding Ig-like Lectin 3 | 2007 |
Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Brain Diseases; Burkitt Lymphoma; Child; Cytarabine; Female; Follow-Up Studies; Humans; Injections, Spinal; Magnetic Resonance Angiography; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sensitivity and Specificity; Treatment Outcome; Vasospasm, Intracranial | 2007 |
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2007 |
[Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Methotrexate; Recurrence; Remission Induction; Rituximab; Translocation, Genetic; Vincristine | 2007 |
Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; B-Lymphocytes; Blood Cell Count; Bone Marrow; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; HIV Infections; Humans; Ifosfamide; Immunoglobulins; Male; Methotrexate; Middle Aged; Prednisolone; Teniposide | 2008 |
Primary hepatic Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cytarabine; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Magnetic Resonance Imaging; Male | 2008 |
Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
Topics: Animals; Burkitt Lymphoma; Chromatography, Paper; Culture Techniques; Cytarabine; Cytosine Nucleotides; Drug Antagonism; Drug Synergism; Kidney; Leukemia L1210; Liver; Lymphoma; Mice; Nucleosides; Oxidation-Reduction; Thymidine; Uracil Nucleotides | 1967 |
Long-term survival of patients with Burkitt's lymphoma: an assessment of treatment and other factors which may relate to survival.
Topics: Adolescent; Antineoplastic Agents; Burkitt Lymphoma; Busulfan; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cytarabine; Female; Humans; Immunotherapy; Infant; Kenya; Male; Mannitol; Melphalan; Methotrexate; Nitrogen Mustard Compounds; Nitroso Compounds; Urea | 1967 |
[Non-Hodgkin's malignant lymphoma. Therapeutic value of autologous bone marrow transplantation].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Thioguanine | 1983 |
Effect of mitomycin C and hydroxyurea on the expression of the Epstein-Barr virus cycle following P3HR-1 superinfection.
Topics: Antigens, Viral; Burkitt Lymphoma; Cell Line; Cytarabine; DNA; DNA, Viral; Herpesvirus 4, Human; Humans; Hydroxyurea; Mitomycins; Nucleic Acid Hybridization | 1980 |
Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
Topics: Antigens, Viral; Burkitt Lymphoma; Cell Line; Cytarabine; DNA, Viral; Gene Expression Regulation; Genes, Viral; Herpesvirus 4, Human; Humans; Hydroxyurea; Phosphonoacetic Acid; Virus Cultivation | 1983 |
Prediction of sensitivity to 1-beta-D-arabinofuranosylcytosine by the plateau level of its 5'-triphosphate in human lymphoblastic cell lines in vitro.
Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Burkitt Lymphoma; Cell Line; Cytarabine; DNA; Humans; Leukemia, Lymphoid | 1983 |
Patterns of treatment failure in Burkitt's lymphoma.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Central Nervous System Diseases; Child; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Humans; Methotrexate; Time Factors; Vincristine | 1983 |
Central nervous system involvement in American Burkitt's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Methotrexate; Prognosis; United States | 1983 |
Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Cytarabine; Drug Therapy, Combination; Female; Hepatic Veins; Humans; Leukemia, Myeloid, Acute; Liver; Liver Diseases; Male; Radiotherapy; Transplantation, Autologous; Transplantation, Homologous; Vascular Diseases | 1980 |
Effects of high-dose cytarabine.
Topics: Adult; Aged; Burkitt Lymphoma; Chromatography, High Pressure Liquid; Cytarabine; Half-Life; Humans; Kinetics; Middle Aged; Radioimmunoassay | 1982 |
Increase in the cytotoxicity of 1-beta-D-arabinofuranosylcytosine due to inhibition of degradation of its triphosphate by hydroxyurea in Burkitt's lymphoma cells.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Burkitt Lymphoma; Cattle; Cells, Cultured; Cytarabine; Humans; Hydroxyurea | 1981 |
Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Hyperkalemia; Hypocalcemia; Methotrexate; Phosphorus Metabolism Disorders; Prednisone; Syndrome; Thioguanine; Uremia; Uric Acid; Vincristine | 1980 |
CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Amsacrine; Aneuploidy; Antibiotics, Antineoplastic; Antigens, CD; Antigens, CD34; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Bone Marrow Transplantation; Burkitt Lymphoma; Cell Differentiation; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Humans; Immunophenotyping; Life Tables; Logistic Models; Male; Middle Aged; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Proportional Hazards Models; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Vincristine | 1995 |
Successful treatment of a patient with seropositive human immunodeficiency virus with high risk Burkitt's leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; HIV Seropositivity; Humans; Hydrocortisone; Injections, Intravenous; Injections, Spinal; Male; Methotrexate; Remission Induction; Renal Dialysis; Vincristine | 1994 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
Chemotherapy with cytosine arabinoside in a child with Burkitt's lymphoma on maintenance hemodialysis and hemofiltration.
Topics: Arabinofuranosyluracil; Burkitt Lymphoma; Child; Cytarabine; Hemofiltration; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Renal Dialysis; Ultraviolet Rays | 1993 |
Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Staging; Vincristine | 1993 |
Favorable response of pediatric AIDS-related Burkitt's lymphoma treated by aggressive chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Humans; Hydrocortisone; Lymphoma, AIDS-Related; Male; Methotrexate; Prednisone; Remission Induction; Vincristine | 1993 |
Ophthalmoparesis due to Burkitt's lymphoma following cardiac transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Heart Transplantation; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone; Middle Aged; Oculomotor Nerve Diseases | 1993 |
Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Burkitt Lymphoma; Child; Cytarabine; Female; Humans; Injections, Spinal; Male; Neurologic Examination; Spinal Cord Diseases; Tomography, X-Ray Computed | 1993 |
Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Hydrocortisone; Infant; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Leukemia-Lymphoma, Adult T-Cell; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide; Treatment Failure | 1993 |
Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Male; Methotrexate; Prognosis; Time Factors; Vincristine | 1993 |
Improved outcome in adult B-cell acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Burkitt Lymphoma; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Leukemic Infiltration; Male; Meninges; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stomatitis; Survival Analysis; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 1996 |
Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
Topics: Acute Disease; Base Sequence; Burkitt Lymphoma; Cytarabine; Dose-Response Relationship, Immunologic; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Molecular Sequence Data; Multiple Myeloma; Neoplasm, Residual; Polymerase Chain Reaction; Transcription, Genetic | 1995 |
Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Heart Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Postoperative Complications; Prednisolone; Remission Induction; T-Lymphocytes, Cytotoxic; Tumor Virus Infections; Vincristine | 1996 |
A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Burkitt Lymphoma; Cytarabine; DNA Fragmentation; Epitopes; fas Receptor; Hematopoietic Stem Cells; HL-60 Cells; Humans; Immunization; Intracellular Membranes; Leukemia-Lymphoma, Adult T-Cell; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Membrane Proteins; Mice; Mice, Inbred BALB C; Mitochondria; Tumor Cells, Cultured | 1996 |
Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Duodenal Neoplasms; Etoposide; Humans; Immunocompromised Host; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Neoplasms, Second Primary; Pancytopenia; Remission Induction; Salvage Therapy; Thigh; Transplantation Conditioning; Vincristine | 1996 |
Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain; Burkitt Lymphoma; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Dexamethasone; Electroencephalography; Humans; Ifosfamide; Injections, Spinal; Male; Methotrexate; Neoplasm Staging; Prednisolone; Tomography, X-Ray Computed; Vincristine | 1997 |
High susceptibility of an Epstein-Barr virus-converted Burkitt's lymphoma cell line to cytotoxic drugs.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Division; Cell Line; Cell Transformation, Viral; Cytarabine; Herpesvirus 4, Human; Humans; Mitomycin; Tumor Cells, Cultured | 1997 |
[Successful treatment with high dose chemotherapy following peripheral blood stem cell transplantation for relapsed Burkitt's lymphoma with central nervous system involvement].
Topics: Adult; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Transplantation, Autologous | 1998 |
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Female; Humans; Injections, Intraventricular; Male; Meningeal Neoplasms; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Treatment Outcome | 1999 |
Differential expression and phosphorylation of CTCF, a c-myc transcriptional regulator, during differentiation of human myeloid cells.
Topics: Blotting, Northern; Blotting, Western; Burkitt Lymphoma; CCCTC-Binding Factor; Cell Differentiation; Cytarabine; Dimethyl Sulfoxide; DNA-Binding Proteins; Down-Regulation; Erythrocytes; Gene Expression Regulation; Humans; Isoelectric Focusing; Leukemia, Myeloid; Leukocytes; Megakaryocytes; Phosphorylation; Proto-Oncogene Proteins c-myc; Repressor Proteins; RNA Processing, Post-Transcriptional; Staurosporine; Tetradecanoylphorbol Acetate; Transcription Factors; Tretinoin; Tumor Cells, Cultured | 1999 |
[Reye syndrome in a child having received chemotherapy].
Topics: Abdominal Neoplasms; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Male; Methotrexate; Prednisone; Reye Syndrome; Vincristine | 1998 |
Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cell Survival; Cytarabine; Drug Carriers; Endocytosis; Hot Temperature; Humans; Lipoproteins, LDL; Liposomes; Protein Binding; Receptors, LDL; Tumor Cells, Cultured | 1999 |
[The presence of minimal residual disease during induction therapy is a reliable factor for the prognosis of recurrence in children with standard-risk B-cell precursor acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; DNA Primers; Genes, T-Cell Receptor delta; Humans; Mercaptopurine; Methotrexate; Molecular Sequence Data; Neoplasm, Residual; Polymerase Chain Reaction; Prednisone; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Vincristine | 1999 |
[Burkitt's lymphoma--a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Methotrexate; Prednisone; Vincristine | 1999 |
Improved outcome in childhood B-cell lymphoma with the intensified French LMB protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Israel; L-Lactate Dehydrogenase; Male; Methotrexate; Retrospective Studies; Survival Analysis; Treatment Outcome | 2000 |
Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis.
Topics: Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Membrane Permeability; Cell Nucleus; Cisplatin; Cytarabine; Doxorubicin; Etoposide; Humans; Hydrogen Peroxide; Kinetics; Oxidative Stress; Phagocytosis; Tumor Cells, Cultured | 2000 |
Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Diseases; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Humans; Hydrocortisone; Incidence; Infant; Injections, Spinal; Italy; Male; Methotrexate; Radiotherapy, Adjuvant; Retrospective Studies | 2000 |
Reversible posterior leukoencephalopathy after combination chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Injections, Spinal; Leukocytes; Magnetic Resonance Imaging; Neurotoxicity Syndromes; Steroids | 2000 |
Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diabetes Insipidus; Disease Progression; Doxorubicin; Dwarfism, Pituitary; False Negative Reactions; Genetic Predisposition to Disease; Human Growth Hormone; Humans; Hydrocortisone; Hypopituitarism; Hypothyroidism; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Pituitary Hormones; Pituitary Neoplasms; Prednisone; Remission Induction; Vincristine | 2001 |
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, B-Cell; Palliative Care; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Treatment Outcome; Vincristine | 2001 |
An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Burkitt Lymphoma; Camptothecin; Cell Survival; Culture Media, Serum-Free; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Topoisomerase Inhibitors; Tumor Cells, Cultured | 2002 |
Burkitt's lymphoma: single-centre experience with modified BFM protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Infections; Lymphoma, AIDS-Related; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Treatment Outcome; Vincristine | 2002 |
Burkitt's lymphoma presenting during lactation.
Topics: Adolescent; Adult; Autopsy; Breast Diseases; Breast Neoplasms; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Female; Humans; Lactation; Male; Methotrexate; Pregnancy | 1976 |
In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
Topics: Animals; Antigens, Neoplasm; Burkitt Lymphoma; Cell Division; Cells, Cultured; Clone Cells; Cytarabine; Cytotoxicity Tests, Immunologic; DNA; Epitopes; Female; Hydroxyurea; Immunity, Cellular; In Vitro Techniques; Leukemia, Experimental; Macrophages; Mast-Cell Sarcoma; Mercaptoethanol; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Plasmacytoma; T-Lymphocytes | 1977 |
Expression of Epstein-Barr-virus-associated membrane antigen in Raji cells superinfected with two different virus strains.
Topics: Antigens, Viral; Burkitt Lymphoma; Cell Line; Cell Membrane; Cycloheximide; Cytarabine; Dactinomycin; Herpesvirus 4, Human; Papain; Puromycin | 1976 |
An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Topics: Animals; Antigens, Viral; B-Lymphocytes; Binding Sites; Burkitt Lymphoma; Cell Line; Cell Nucleus; Child, Preschool; Cytarabine; Herpesvirus 4, Human; Humans; Idoxuridine; Male; Mice; Neoplasm Transplantation | 1975 |
Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
Topics: Antigens, Viral; Burkitt Lymphoma; Capsid; Cell Line; Cell Membrane; Cytarabine; Herpesvirus 4, Human; Phosphonoacetic Acid; Puromycin; Trypsin | 1978 |
Early and late components of Epstein-Barr virus-associated membrane antigen in superinfected Daudi cells and their reactivity with sera from nasopharyngeal carcinoma patients.
Topics: Agglutination; Antibodies, Viral; Antigens, Viral; Burkitt Lymphoma; Capsid; Carcinoma; Cell Line; Cell Membrane; Cytarabine; Fluorescent Antibody Technique; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms; Puromycin | 1978 |
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse.
Topics: Adolescent; Adult; Burkitt Lymphoma; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Myocarditis; Remission, Spontaneous; Thioguanine | 1978 |
Management of Burkitt's lymphoma involving the central nervous system.
Topics: Antineoplastic Agents; Brain Neoplasms; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Humans; Lomustine; Methotrexate; Nitrosourea Compounds; Spinal Cord Neoplasms; Vincristine | 1976 |
Combination chemotherapy in abdominal Burkitt's lymphoma.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Agents; Burkitt Lymphoma; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Remission, Spontaneous; Vincristine | 1977 |
Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Hydrocortisone; Injections, Spinal; Leukemia, Lymphoid; Leukoencephalopathy, Progressive Multifocal; Male; Meninges; Methotrexate; Radiotherapy; Vincristine | 1975 |
Leukoencephalopathy following combined therapy of central nervous system leukemia and lymphoma.
Topics: Axons; Brain; Brain Diseases; Burkitt Lymphoma; Central Nervous System Diseases; Child; Cytarabine; Humans; Injections, Spinal; Leukemia, Lymphoid; Meninges; Methotrexate; Necrosis; Radiotherapy | 1975 |
Relapse in Burkitt's lymphoma.
Topics: Abdominal Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Facial Neoplasms; Follow-Up Studies; Humans; Methotrexate; Recurrence; Remission, Spontaneous; Vincristine | 1976 |
Treatment of poor prognosis Burkitt's lymphoma in adults with the Société Française d'Oncologie Pédiatrique LMB Protocol--a study of the Federation Nationale des Centres de Lutte Contre le Cancer (FNLCC).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Time Factors | 1992 |
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Methotrexate; Prednisone; Prognosis; Recurrence; Remission Induction; Teniposide; Vincristine | 1992 |
Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone ma
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antigens, Neoplasm; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Burkitt Lymphoma; CD24 Antigen; Complement System Proteins; Cyclophosphamide; Cytarabine; Flow Cytometry; Fluorescent Antibody Technique; Humans; Membrane Glycoproteins; Neoplasm Recurrence, Local; Neprilysin; Rabbits; Remission Induction; Tetraspanin 29; Transplantation, Autologous; Tumor Stem Cell Assay; Whole-Body Irradiation | 1992 |
Therapy of acute lymphoblastic leukemia in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Hematopoietic Cell Growth Factors; Humans; Leukemia-Lymphoma, Adult T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction | 1992 |
Percutaneous lumbar intrathecal catheter for the administration of chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Catheterization, Peripheral; Cytarabine; Humans; Injections, Spinal; Laminectomy; Male; Methotrexate | 1991 |
[Long-term remission of a case of Burkitt's lymphoma accompanied by cardiac tamponade treated by surgical resection and intensive chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cardiac Tamponade; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Intestinal Obstruction; Methotrexate; Pericardial Effusion; Pleural Effusion; Remission Induction; Vincristine | 1990 |
'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine | 1990 |
Massive chemotherapy and autologous bone marrow transplantation in Burkitt's lymphoma: the first two patients successfully treated in Thailand.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Humans; Male; Thailand; Thioguanine | 1990 |
Burkitt's lymphoma in a 45-year-old Nigerian woman.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Female; Humans; Middle Aged; Ovarian Neoplasms; Vincristine | 1990 |
[Transverse leukonychia and anti-leukemia chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Male; Methotrexate; Nail Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1990 |
[Chemotherapy of nonendemic Burkitt's lymphoma].
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Prednisone; Teniposide | 1990 |
Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Reoperation; Transplantation, Autologous; Transplantation, Homologous; Vincristine | 1989 |
Intrathecal cytosine arabinoside-induced acute, rapidly reversible paralysis.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cytarabine; Humans; Injections, Spinal; Male; Middle Aged; Paraplegia | 1989 |
Intraocular involvement of Burkitt's lymphoma in a Bedouin child.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Burkitt Lymphoma; Carmustine; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Humans; Hydrocortisone; Methotrexate; Vincristine; Vitreous Body | 1987 |
Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukemia, Lymphoid; Male; Methotrexate; Neoplasm Staging | 1986 |
Effective treatment of lymphomas of Burkitt's type and B-ALL in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infusions, Parenteral; Injections, Spinal; Leucovorin; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Prednisolone; Teniposide | 1985 |
Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
Topics: Acute Disease; Adolescent; Adult; B-Lymphocytes; Bacterial Infections; Burkitt Lymphoma; Cerebellar Ataxia; Child; Child, Preschool; Cytarabine; Female; Gastrointestinal Diseases; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Neutropenia; Recurrence; Thrombocytopenia | 1985 |
High-dose adriamycin combination chemotherapy for intermediate and high-grade non-Hodgkin's lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Neutropenia; Prednisone; T-Lymphocytes; Thrombocytopenia; Vincristine | 1985 |
Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.
Topics: Adolescent; Antigens; Biopsy; Burkitt Lymphoma; Cell Membrane; Cell Transformation, Neoplastic; Culture Techniques; Cytarabine; Fluorescent Antibody Technique; gamma-Globulins; Humans; Male; Surface Properties | 1968 |
Acute leukemias and Burkitt's lymphoma. Present status of therapy.
Topics: Antineoplastic Agents; Asparaginase; Burkitt Lymphoma; Choriocarcinoma; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Female; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Melphalan; Mercaptopurine; Methotrexate; Prednisone; Pregnancy; Vincristine; Wilms Tumor | 1968 |
[Viral pathology: concepts of yesterday and today].
Topics: Adult; Burkitt Lymphoma; Child; Cytarabine; Encephalitis; Female; Herpes Simplex; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Male; Rifampin; Virus Diseases | 1973 |
Burkitt's lymphoma: cell kinetics, treatment and immunology.
Topics: Antibodies, Neoplasm; Antibodies, Viral; Burkitt Lymphoma; Culture Techniques; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Herpesvirus 4, Human; Humans; Hypersensitivity, Delayed; Injections, Spinal; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Thymidine; Tritium; Vincristine | 1973 |
Enhanced activation of the repressed Epstein-Barr viral genome by inhibitors of DNA synthesis.
Topics: Burkitt Lymphoma; Cell Line; Cell Transformation, Neoplastic; Cytarabine; DNA; Genotype; Herpesvirus 4, Human; Hydroxyurea; Mitosis; Thymidine; Time Factors; Virus Replication | 1974 |
Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment.
Topics: Antibodies, Neoplasm; Antigen-Antibody Reactions; Antigens, Neoplasm; Antigens, Viral; BCG Vaccine; Burkitt Lymphoma; Cell Membrane; Child, Preschool; Complement Fixation Tests; Cytarabine; Diphtheria Antitoxin; Facial Neoplasms; Herpesvirus 4, Human; Humans; Kidney Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Pertussis Vaccine; Tetanus Antitoxin | 1973 |
Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
Topics: Absorption; Antigen-Antibody Complex; Antigens, Viral; Burkitt Lymphoma; Cell Line; Cell Membrane; Cells, Cultured; Cytarabine; DNA, Viral; Fluorescent Antibody Technique; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms | 1974 |
Programming of events in Epstein-Barr virus-activated cells induced by 5-iododeoxyuridine.
Topics: Antigens, Viral; Autoradiography; Burkitt Lymphoma; Cell Line; Cells, Cultured; Cytarabine; Deoxycytidine; DNA Replication; DNA, Neoplasm; DNA, Viral; Fluorescent Antibody Technique; Herpesvirus 4, Human; Humans; Hydroxyurea; Idoxuridine; Mitosis; Thymidine; Time Factors; Tritium; Viral Proteins; Virus Replication | 1974 |
Observations on the resistance of Fpstein-Barr virus DNA synthesis to hydroxyurea.
Topics: Antigens, Viral; Burkitt Lymphoma; Cell Line; Cytarabine; Depression, Chemical; DNA Replication; DNA, Viral; Fluorescent Antibody Technique; Herpesvirus 4, Human; Hybrid Cells; Hydroxyurea; Idoxuridine; Nucleic Acid Hybridization; Thymidine; Tritium | 1974 |
[Burkitt's tumor: etiology, clinic and therapy (author's transl)].
Topics: Adolescent; Adult; Africa, Central; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Herpesvirus 4, Human; Humans; Male; Mandibular Neoplasms; Maxillary Neoplasms; Methotrexate; Prognosis; Vincristine | 1974 |
Antiviral effect of asparaginase and of Burkitt cell extracts in combination with other drugs.
Topics: Amines; Animals; Antiviral Agents; Asparaginase; Burkitt Lymphoma; Cell Line; Chick Embryo; Cricetinae; Cytarabine; Cytopathogenic Effect, Viral; Deoxyribonucleases; Deoxyuridine; Drug Combinations; Drug Interactions; Humans; Iodine; Piperazines; Rabbits; Simplexvirus; Tissue Extracts; Viral Plaque Assay; Virus Cultivation | 1974 |
Intracerebral Burkitt's lymphoma: pathology, clinical features and treatment.
Topics: Adolescent; Allopurinol; Brain Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Hydroxyurea; Male; Methotrexate; Neoplasm Metastasis; Papilledema; Prednisolone; Vincristine | 1974 |
Eventual control of clinical leukemia.
Topics: Administration, Oral; Africa; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; United States; Vincristine | 1973 |
Chemotherapy of Burkitt's lymphoma.
Topics: Antineoplastic Agents; BCG Vaccine; Burkitt Lymphoma; Cell Transformation, Neoplastic; Cyclophosphamide; Cytarabine; Follow-Up Studies; Humans; Immunotherapy; Methotrexate; Nitrosourea Compounds; Prognosis; Remission, Spontaneous; Time Factors; Vincristine | 1972 |
Neurological manifestations of Burkitt's lymphoma in Ghana.
Topics: Antineoplastic Agents; Burkitt Lymphoma; Cerebrospinal Fluid; Cranial Nerves; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Female; Ghana; Headache; Humans; Male; Methotrexate; Neurologic Manifestations; Paraplegia; Vincristine | 1973 |
Status and perspectives in chemotherapy of Hodgkin's disease.
Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Evaluation Studies as Topic; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Mice; Mitosis; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1973 |
Burkitt's tumor.
Topics: Africa; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Jaw Neoplasms; Methotrexate; Vincristine | 1973 |
Burkitt's lymphoma involving the kidney: urographic findings before and after therapy in an American child.
Topics: Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Humans; Kidney Neoplasms; Male; Prednisone; Ultrasonics; United States; Urography; Vincristine | 1974 |
Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established Burkitt lymphoma cell lines.
Topics: Antimetabolites; Biotransformation; Burkitt Lymphoma; Cell Line; Culture Techniques; Cytarabine; Dactinomycin; Fluorescent Antibody Technique; Humans; Membranes; Methotrexate; Mitomycins; Puromycin | 1970 |
The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines.
Topics: Antigens; Autoradiography; Burkitt Lymphoma; Cell Line; Cytarabine; Cytosine Nucleotides; DNA; DNA, Viral; Fluorescent Antibody Technique; Herpesviridae; Idoxuridine; In Vitro Techniques; Nasopharyngeal Neoplasms; Puromycin; Thymidine; Tritium | 1971 |
Summary: recent advances in the treatment of acute leukemia and Burkitt's tumor.
Topics: Antineoplastic Agents; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Nitroso Compounds; Prednisone; Urea; Vincristine | 1967 |
Treatment of acute leukemia.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Burkitt Lymphoma; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Prognosis; Thioguanine; Time Factors; Vincristine | 1968 |
Leukemia and lymphoma.
Topics: Antineoplastic Agents; BCG Vaccine; Burkitt Lymphoma; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Prednisone; Vincristine | 1970 |
Treatment of Burkitt's tumor with cyclophosphamide.
Topics: Abdominal Neoplasms; Adult; Brain Neoplasms; Burkitt Lymphoma; Child; Cranial Nerves; Cyclophosphamide; Cytarabine; Facial Neoplasms; Female; Humans; Injections, Spinal; Male; Mandibular Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Uganda; Vincristine | 1970 |
Central nervous system involvement in Burkitt's lymphoma.
Topics: Brain Neoplasms; Burkitt Lymphoma; Central Nervous System Diseases; Cerebrospinal Fluid; Cognition Disorders; Cyclophosphamide; Cytarabine; Folic Acid; Humans; Injections, Spinal; Lymphocytosis; Methotrexate; Neoplasm Metastasis; Paraplegia; Vincristine | 1970 |
Treatment of Burkitt's lymphoma with cyclophosphamide.
Topics: Burkitt Lymphoma; Cerebrospinal Fluid; Cyclophosphamide; Cytarabine; Humans; Injections, Spinal; Methotrexate | 1970 |
Nucleosides. 48. Synthesis of 1-(5-deoxy-beta-D-arabinosyl)cytosine and related compounds.
Topics: Animals; Burkitt Lymphoma; Carbonates; Cytarabine; Humans; Leukemia L1210; Methods; Mice; Nucleosides; Sulfur; Thiouracil; Uracil | 1968 |